LEOBENDORF, Austria--(BUSINESS WIRE)--#aestheticmedicine--Croma-Pharma, a global player in minimally invasive aesthetic medicine, proudly announces the launch of its new medical device that is used ...

A new platelet-rich fibrin (PRF) matrix is becoming a promising and affordable alternative for treating chronic diabetic ulcers (diabetic foot), a pilot study conducted in São Paulo, Brazil, suggests.

This launch represents continued progress in Croma's mission to provide healthcare professionals state-of-the-art tools for their practice. Exprecell(TM) is now available for healthcare professionals ...

Croma-Pharma, a global player in minimally invasive aesthetic medicine, proudly announces the launch of its new medical device that is used for the preparation of autologous Platelet-Rich Plasma (PRP) ...